NFKB1 and metabolic syndrome: extract reduced weight gain, hepatic lipid deposition, and improved dyslipidemia, inflammation, oxidative stress, and insulin resistance in HFD-fed mice via the regulation of the NF-κB/iNOS/COX-2/NLRP3/MAPK pathway [35].